Blend Labs (BLND) EBITDA (2020 - 2026)

Blend Labs' EBITDA history runs 7 years deep, the most recent figure standing at -$5.1 million for Q1 2026.

• On a quarterly basis, EBITDA rose 36.58% year-over-year to -$5.1 million in Q1 2026; TTM through Mar 2026 was -$18.8 million, a 47.15% increase from a year earlier, with the FY2025 full-year figure at -$21.7 million, up 55.5% from the prior year.
• EBITDA declined to -$5.1 million in Q1 2026 per BLND's latest filing, from -$3.6 million in the prior quarter.
• Across five years, EBITDA topped out at -$3.3 million in Q4 2024 and bottomed at -$471.4 million in Q2 2022.
• The 5-year median for EBITDA is -$13.1 million (2024), against an average of -$56.8 million.
• Across the five-year window, EBITDA sank 1089.42% in 2022 and jumped 92.21% in 2023, its largest moves.
• Year by year, EBITDA stood at -$75.2 million in 2022, then surged by 87.69% to -$9.3 million in 2023, then jumped by 64.64% to -$3.3 million in 2024, then dropped by 9.47% to -$3.6 million in 2025, then sank by 41.29% to -$5.1 million in 2026.
• Per Business Quant, the three latest BLND EBITDA figures stand at -$5.1 million (Q1 2026), -$3.6 million (Q4 2025), and -$5.3 million (Q3 2025).